The European Union has published a draft amendment to Regulation (EC) No 1223/2009 on cosmetic products, introducing proposed updates to Annex II (List of Prohibited Substances), Annex III (List of Restricted Substances), and Annex V (List of Preservatives Allowed in Cosmetic Products). The public consultation period is open until 6 September 2026, and the Regulation is expected to be adopted during the last quarter of 2026, entering into force 20 days after its publication in the Official Journal of the European Union. Purpose of the Amendment The proposed amendment aims to update the EU Cosmetics Regulation in line with the latest classifications of carcinogenic, mutagenic, and toxic for reproduction (CMR) substances. Certain substances newly classified as CMR are proposed to be prohibited in cosmetic products, while the conditions of use for several existing cosmetic ingredients are being revised based on the latest scientific opinions issued by the Scientific Committee on...
With less than two months remaining until the first mandatory requirements of the EU Packaging...
Canada has announced new regulatory measures aimed at strengthening oversight of chemical substances used in cosmetics and consumer products. Regulatory notices published on 27 June 2026 introduce immediate conditions for the use of Castor Oil, Monomaleate, while proposing new notification requirements for Triethanolamine (TEA), N, N-Diethanoldodecanamide (LDE) and Cocamide DEA (CDE). New Conditions for Castor Oil, Monomaleate Under measures published by Environment and Climate Change Canada, the manufacture and import of Castor Oil, Monomaleate are now subject to specific regulatory conditions after the substance was identified as potentially toxic or capable of becoming toxic under certain circumstances. The ministerial conditions entered into force on 10 June 2026 and are immediately applicable to relevant manufacturers and importers. Proposed Significant New Activity (SNAc) Requirements Canada has also proposed applying Significant New Activity...
The Turkish Medicines and Medical Devices Agency (TİTCK) has introduced a comprehensive regulatory framework for aromatherapeutic products through the...
The U.S. Food and Drug Administration (FDA) has updated its regulatory agenda for cosmetic products. According to...
On 10 July 2026, the Turkish Medicines and Medical Devices Agency (TİTCK),...
The Turkish Medicines and Medical Devices Agency (TİTCK), through its Vice Presidency for Inspection Services, published the results of cosmetic market surveillance and inspection activities carried out during the second quarter of 2026 (April–June 2026).
The European Commission has notified the World Trade Organization (WTO) of Omnibus Act IX, a draft amendment introducing new ingredient bans and restrictions under the EU Cosmetics Regulation. The proposal incorporates substances classified as CMRs (carcinogenic, mutagenic, or toxic for reproduction) as well as recent safety assessments issued by the Scientific Committee on Consumer Safety (SCCS).
The European Commission has issued a new mandate to the Scientific Committee...
The Ministry of Environment, Urbanization and Climate Change of the Republic of...